In today’s competitive digital world, businesses need reliable technology partners who can build scalable software, powerful mobile apps, & high-performance.
Read MoreJoin the ZKP crypto project and explore its decentralized AI network. Get early access to presale tokens in the crypto presale 2026.
Read MoreAccording to a new report from Intel Market Research, the global Targeted Drugs for Parkinson's Disease market was valued at USD 4.8 billion in 2025 and is projected to reach USD 9.1 billion by 2034, growing at a steady CAGR of 7.2% during the forecast period (2025–2034). This growth is fueled by increasing global prevalence of Parkinson's disease, rising geriatric populations, and advancements in precision medicine approaches targeting specific neurodegenerative pathways.
Read MoreAccording to a new report from Intel Market Research, the global Isoflurane Anesthesia Drugs market was valued at USD 19.89 million in 2025 and is projected to reach USD 26.86 million by 2034, growing at a steady CAGR of 4.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding surgical volumes worldwide and sustained demand for cost-effective inhalation anesthetics, though environmental concerns pose challenges to market expansion.
Read MoreAccording to a new report from Intel Market Research, the global Neuraxial Anesthesia Drug market was valued at USD 1.25 billion in 2025 and is projected to reach USD 1.76 billion by 2034, growing at a steady CAGR of 5.1% during the forecast period (2026-2034). This growth trajectory reflects the increasing preference for regional anesthesia techniques in surgical procedures, particularly in obstetrics and orthopedic applications where neuraxial anesthesia offers superior safety and recovery profiles compared to general anesthesia.
Read More